
|Articles|November 1, 1999
Supplements and Featured Publications
- The Clinical and Economic Impact of Pneumococcal Disease in the Pediatric Population
- Volume 5
- Issue 17 Suppl
Epidemiology of Pneumococcal Disease
Author(s)Chris Van Beneden, MD, MPH
Advertisement
Articles in this issue
about 26 years ago
Participating Facultyabout 26 years ago
Introductionabout 26 years ago
The Costs of Antimicrobial Treatment Failure in Acute Otitis Mediaabout 26 years ago
Prevention of Pneumococcal Disease in High-Risk Pediatric Groupsabout 26 years ago
The Clinical Impact of Pneumococcal Conjugate Vaccinesabout 26 years ago
Economic Impact of Pneumococcal Conjugate Vaccine in Managed Careabout 26 years ago
Into the Era of the Pneumococcal Conjugate Vaccineabout 26 years ago
Selected Abstractsabout 26 years ago
CME Quizabout 26 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Contributor: Engagement Is the Missing Link in Kidney Care—How Payers and Value-Based Partnerships Can Close the Gap
2
Different Communication of HIV Risk Affects PrEP Interest
3
FDA Approves Pembrolizumab Plus Enfortumab Vedotin for MIBC
4
BPA Exposure Linked to 127 Million Global Metabolic Disease Cases
5















































